• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    LFW Photonics Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Terns Pharmaceuticals Inc (NQ: TERN )

    7.330 +0.100 (+1.38%)
    Streaming Delayed Price Updated: 4:00 PM EDT, Sep 4, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 833,911
    Open 7.180
    Bid (Size) 6.800 (10)
    Ask (Size) 7.750 (1)
    Prev. Close 7.230
    Today's Range 6.980 - 7.400
    52wk Range 3.260 - 10.03
    Shares Outstanding N/A
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    The 9 Pharma Stocks To Watch — Including Viking, Roche And Amgen — Amid The Fast-Growing Obesity Drug Race
    The race to develop the next big obesity treatment is on with leaders Lilly and Novo trying to keep their top slots. 
    Via Investor's Business Daily
    TERN Stock Earnings: Terns Pharma Beats EPS for Q2 2024
    TERN stock results show that Terns Pharma beat analyst estimates for earnings per share the second quarter of 2024. 
    Via InvestorPlace

    Performance

    YTD
    +13.12%
    +13.12%
    1 Month
    +0.27%
    +0.27%
    3 Month
    +6.70%
    +6.70%
    6 Month
    -10.50%
    -10.50%
    1 Year
    +38.83%
    +38.83%

    More News

    Read More
    Terns Pharmaceuticals Reports Second Quarter 2024 Financial Results and Corporate Updates
    From Terns Pharmaceuticals, Inc.
    Via GlobeNewswire
    3 Biotech Stocks That Could Have Investors Grinning Soon
    Via InvestorPlace
    Terns Pharmaceuticals Reports Inducement Grant to New Employee Under Nasdaq Listing Rule 5635(C)(4)
    From Terns Pharmaceuticals, Inc.
    Via GlobeNewswire
    TERN Stock Earnings: Terns Pharma Meets EPS for Q4 2023
    Via InvestorPlace
    Terns Pharmaceuticals Appoints Biotech Executive Elona Kogan as Chief Legal Officer and Announces Upcoming CFO Transition
    From Terns Pharmaceuticals, Inc.
    Via GlobeNewswire
    Can These 2 Biotechs Beat Eli Lilly and Novo Nordisk in Weight-Loss Drugs?
    Via The Motley Fool
    EXCLUSIVE: Weight-Loss Duopoly Breaks As Eli Lilly, Novo Plummet; 'Market Won't Be Dominated By Just 2 Players'
    Via Benzinga
    Why ConAgra Brands Shares Are Trading Lower? Here Are Other Stocks Moving In Thursday's Mid-Day Session
    Via Benzinga
    Methode Electronics Posts Strong Sales, Joins QuantumScape, Ribbon Communications And Other Big Stocks Moving Higher On Thursday
    Via Benzinga
    Terns Pharmaceuticals Highlights New Preclinical Data Supporting TERN-501 in Combination with a GLP-1R Agonist for Obesity at the ADA’s 84th Annual Scientific Sessions and Upcoming Conference Participation
    From Terns Pharmaceuticals, Inc.
    Via GlobeNewswire
    Terns Pharmaceuticals Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(C)(4)
    From Terns Pharmaceuticals, Inc.
    Via GlobeNewswire
    Terns Pharmaceuticals to Participate in Upcoming June Investor Conferences
    From Terns Pharmaceuticals, Inc.
    Via GlobeNewswire
    Terns Pharmaceuticals to Participate in UBS Obesity Therapeutics Day
    From Terns Pharmaceuticals, Inc.
    Via GlobeNewswire
    TERN Stock Earnings: Terns Pharma Beats EPS for Q1 2024
    Via InvestorPlace
    Terns Pharmaceuticals Reports First Quarter 2024 Financial Results and Corporate Updates
    From Terns Pharmaceuticals, Inc.
    Via GlobeNewswire
    Terns Pharmaceuticals Announces Leadership Changes
    From Terns Pharmaceuticals, Inc.
    Via GlobeNewswire
    Terns Pharmaceuticals to Participate in The Citizens JMP Life Sciences Conference 2024
    From Terns Pharmaceuticals, Inc.
    Via GlobeNewswire
    Terns Pharmaceuticals Reports Inducement Grant to New Employee Under Nasdaq Listing Rule 5635(C)(4)
    From Terns Pharmaceuticals, Inc.
    Via GlobeNewswire
    Terns Pharmaceuticals Announces Data from Ongoing Phase 1 Pharmacokinetic Study of Allosteric BCR-ABL Inhibitor TERN-701 in Adult Healthy Volunteers and Highlights Potential for Competitive Differentiation
    From Terns Pharmaceuticals, Inc.
    Via GlobeNewswire
    Terns Pharmaceuticals Appoints Melita Sun Jung as Chief Business Officer
    From Terns Pharmaceuticals, Inc.
    Via GlobeNewswire
    Wall Street’s Favorite Biotech Stocks? 3 Names That Could Make You Filthy Rich
    Via InvestorPlace
    12 Health Care Stocks Moving In Thursday's After-Market Session
    Via Benzinga
    Madrigal Pharmaceuticals Wins Approval for the First Drug Targeting the Multibillion-Dollar NASH Market. Is the Stock a Screaming Buy?
    Via The Motley Fool
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.